28 May 2019

United Therapeutics Corporation To Present at Jefferies 2019 Healthcare Conference

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 28, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United...

Download pdf

07 May 2019

United Therapeutics And DEKA Announce FDA Clearance Of The Unity Subcutaneous Delivery System For Remodulin®

RESEARCH TRIANGLE PARK, N.C. and MANCHESTER, N.H., May 7, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) and DEKA Research & Development Corp. today announced receipt of 510(k) clearance by the U...

Download pdf

01 May 2019

United Therapeutics Corporation Reports First Quarter 2019 Financial Results

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 1, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended March 31...

Download pdf

29 Apr 2019

United Therapeutics Announces FDA Approval Of XPS™ And Steen Solution™ Used To Perform Centralized Ex-Vivo Lung Perfusion Services

SILVER SPRING, Md., April 29, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that its collaborator, XVIVO Perfusion, Inc., a subsidiary of XVIVO Perfusion AB (STO: XVIVO), has...

Download pdf

24 Apr 2019

United Therapeutics Corporation To Report First Quarter 2019 Financial Results Before The Market Opens On Wednesday, May 1, 2019

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 24, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2019 financial results before the...

Download pdf

17 Apr 2019

United Therapeutics Issues Statement In Response To Meritless Lawsuit

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 17, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) was named as a defendant, along with Smiths Medical ASD, Inc., in a lawsuit filed in...

Download pdf

08 Apr 2019

United Therapeutics Announces BEAT Study of Esuberaprost Does Not Meet Primary Endpoint

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 8, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that the BEAT clinical study of esuberaprost tablets in patients suffering...

Download pdf

12 Mar 2019

United Therapeutics Corporation to Present at Oppenheimer 29th Annual Healthcare Conference

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 12, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of...

Download pdf

04 Mar 2019

United Therapeutics Corporation To Present At Cowen And Company 39th Annual Health Care Conference

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 4, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United...

Download pdf

27 Feb 2019

United Therapeutics Corporation Reports 2018 Fourth Quarter And Annual Financial Results

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the fourth quarter and year ended December...

Download pdf

20 Feb 2019

United Therapeutics Corporation To Report Fourth Quarter And Annual 2018 Financial Results Before The Market Opens On Wednesday, February 27, 2019

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 20, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its fourth quarter and annual 2018 financial results...

Download pdf

31 Jan 2019

Survival Data From FREEDOM-EV Study of Orenitram Presented at the Pulmonary Vascular Research Institute Annual World Congress

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Jan. 31, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that key data from the FREEDOM-EV study of Orenitram® (treprostinil)...

Download pdf